The effect of an electronic monitoring device with audiovisual reminder function on adherence to inhaled corticosteroids and school attendance in children with asthma: a randomised controlled trial
- PMID: 25617215
- DOI: 10.1016/S2213-2600(15)00008-9
The effect of an electronic monitoring device with audiovisual reminder function on adherence to inhaled corticosteroids and school attendance in children with asthma: a randomised controlled trial
Abstract
Background: Suboptimum adherence to preventive asthma treatment is associated with substantial morbidity and mortality, yet adherence often remains poor. We aimed to investigate whether use of an inhaler with audiovisual reminders leads to improved adherence and asthma outcomes in school-aged children who presented to the emergency department with an asthma exacerbation.
Methods: We did a randomised controlled trial in patients aged 6-15 years who attended the regional emergency department in Auckland, New Zealand with an asthma exacerbation and were on regular inhaled corticosteroids. Using a simple, unrestricted block randomisation with block sizes of 200, we randomly assigned patients to receive an electronic monitoring device for use with their preventer inhaler with the audiovisual reminder functions either enabled to support adherence to inhaled corticosteroids (intervention group) or disabled (control group). Participants were followed up every 2 months for 6 months. The primary outcomes were adherence to preventive inhaled corticosteroids and number of days absent from school for any reason. Asthma control was assessed as a secondary outcome. All analyses were done in the intention-to-treat population. This trial is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12613001353785.
Findings: The study took place between May 10, 2010, and Feb 26, 2012. We randomly assigned 220 patients, 110 to the intervention group and 110 to the control group. Median percentage adherence was 84% (10th percentile 54%, 90th percentile 96%) in the intervention group, compared with 30% (8%, 68%) in the control group (p<0·0001). The proportion of days absent from school for any reason was 1·9% (10th percentile 0·0%, 90th percentile 7·9%) in the intervention group and 1·7% (0·0%, 8·6%) in the control group. The change in asthma morbidity score from baseline to 6 months was significantly greater in the intervention group than in the control group (p=0·008), with a reduction of 2·0 points from a mean baseline score of 9·3 (SD 2·2) to 7·3 (2·1) in the intervention group, compared with a reduction of 1·2 points from a baseline of 9·2 (2·5) to 8·0 (2·2) in the control group.
Interpretation: Use of an electronic monitoring device with an audiovisual reminder led to significant improvements in adherence to inhaled corticosteroids in school-aged children with asthma. This intervention could be beneficial for the improvement of asthma control in patients for whom poor asthma control is related to poor adherence.
Funding: Health Research Council of New Zealand and Cure Kids.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Comment in
-
Monitoring and adherence in asthma management.Lancet Respir Med. 2015 Mar;3(3):175-6. doi: 10.1016/S2213-2600(15)00009-0. Epub 2015 Jan 21. Lancet Respir Med. 2015. PMID: 25617214 No abstract available.
Similar articles
-
STAAR: a randomised controlled trial of electronic adherence monitoring with reminder alarms and feedback to improve clinical outcomes for children with asthma.Thorax. 2017 Apr;72(4):347-354. doi: 10.1136/thoraxjnl-2015-208171. Epub 2016 Nov 4. Thorax. 2017. PMID: 27815524 Clinical Trial.
-
Pragmatic trial of health care technologies to improve adherence to pediatric asthma treatment: a randomized clinical trial.JAMA Pediatr. 2015 Apr;169(4):317-23. doi: 10.1001/jamapediatrics.2014.3280. JAMA Pediatr. 2015. PMID: 25664620 Clinical Trial.
-
Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial.Lancet Respir Med. 2013 Mar;1(1):32-42. doi: 10.1016/S2213-2600(13)70007-9. Epub 2013 Mar 4. Lancet Respir Med. 2013. PMID: 24321802 Clinical Trial.
-
Adherence to inhaled corticosteroids: comparison of available therapies.Pulm Pharmacol Ther. 2010 Oct;23(5):384-8. doi: 10.1016/j.pupt.2010.06.001. Epub 2010 Jun 11. Pulm Pharmacol Ther. 2010. PMID: 20542129 Review.
-
Clinical effectiveness of inhaled corticosteroids versus montelukast in children with asthma: prescription patterns and patient adherence as key factors.Curr Med Res Opin. 2012 Jan;28(1):111-9. doi: 10.1185/03007995.2011.640668. Epub 2011 Dec 16. Curr Med Res Opin. 2012. PMID: 22077107 Review.
Cited by
-
An approach to the management of children with problematic severe asthma.Acta Biomed. 2020 Sep 7;91(3):e2020055. doi: 10.23750/abm.v91i3.9603. Acta Biomed. 2020. PMID: 32921752 Free PMC article. Review.
-
Encouraging adherence in adolescents with asthma using financial incentives: An RCT.Pediatr Pulmonol. 2023 Oct;58(10):2823-2831. doi: 10.1002/ppul.26594. Epub 2023 Jul 14. Pediatr Pulmonol. 2023. PMID: 37449768 Free PMC article. Clinical Trial.
-
Short-term effect of a smart nebulizing device on adherence to inhaled corticosteroid therapy in Asthma Predictive Index-positive wheezing children.Patient Prefer Adherence. 2018 May 18;12:861-868. doi: 10.2147/PPA.S162744. eCollection 2018. Patient Prefer Adherence. 2018. PMID: 29849453 Free PMC article.
-
Meta-Analysis of Adherence Promotion Interventions in Pediatric Asthma.J Pediatr Psychol. 2021 Oct 18;46(10):1195-1212. doi: 10.1093/jpepsy/jsab057. J Pediatr Psychol. 2021. PMID: 34343294 Free PMC article.
-
Inhalable Nanotechnology-Based Drug Delivery Systems for the Treatment of Inflammatory Lung Diseases.Pharmaceutics. 2025 Jul 9;17(7):893. doi: 10.3390/pharmaceutics17070893. Pharmaceutics. 2025. PMID: 40733101 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical